エピジェネティクス市場は2023年から2028年に14億7,778万米ドル、予測期間中のCAGRは14.75%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、非腫瘍性疾患におけるエピジェネティック・アプリケーションの増加、CVDの有病率の増加、ベンダー間の戦略的協力関係の高まりによって牽引されています。
本調査では、今後数年間のエピジェネティクス市場の成長を牽引する主な要因として、ライフサイエンス業界の技術進歩を挙げています。また、ゲノムプロジェクトの増加やエピジェネティクスの最近の市場開拓の増加は、市場の大きな需要につながります。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global epigenetics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global epigenetics market 2018 - 2022 ($ million)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Oncology - Market size and forecast 2023-2028
Exhibit 34: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
6.4 Non-oncology - Market size and forecast 2023-2028
Exhibit 38: Chart on Non-oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Non-oncology - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Non-oncology - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Non-oncology - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Application
Exhibit 42: Market opportunity by Application ($ million)
Exhibit 43: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 44: Chart on Product - Market share 2023-2028 (%)
Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 46: Chart on Comparison by Product
Exhibit 47: Data Table on Comparison by Product
7.3 Reagents - Market size and forecast 2023-2028
Exhibit 48: Chart on Reagents - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Reagents - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Reagents - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Reagents - Year-over-year growth 2023-2028 (%)
7.4 Kits - Market size and forecast 2023-2028
Exhibit 52: Chart on Kits - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Kits - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Kits - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Kits - Year-over-year growth 2023-2028 (%)
7.5 Enzymes and others - Market size and forecast 2023-2028
Exhibit 56: Chart on Enzymes and others - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Enzymes and others - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Enzymes and others - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Enzymes and others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Product
Exhibit 60: Market opportunity by Product ($ million)
Exhibit 61: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Abcam plc
Exhibit 111: Abcam plc - Overview
Exhibit 112: Abcam plc - Product / Service
Exhibit 113: Abcam plc - Key news
Exhibit 114: Abcam plc - Key offerings
12.4 Active Motif Inc.
Exhibit 115: Active Motif Inc. - Overview
Exhibit 116: Active Motif Inc. - Product / Service
Exhibit 117: Active Motif Inc. - Key offerings
12.5 Agilent Technologies Inc.
Exhibit 118: Agilent Technologies Inc. - Overview
Exhibit 119: Agilent Technologies Inc. - Business segments
Exhibit 120: Agilent Technologies Inc. - Key offerings
Exhibit 121: Agilent Technologies Inc. - Segment focus
12.6 Bio Rad Laboratories Inc.
Exhibit 122: Bio Rad Laboratories Inc. - Overview
Exhibit 123: Bio Rad Laboratories Inc. - Business segments
Exhibit 124: Bio Rad Laboratories Inc. - Key news
Exhibit 125: Bio Rad Laboratories Inc. - Key offerings
Exhibit 126: Bio Rad Laboratories Inc. - Segment focus
12.7 Eisai Co. Ltd.
Exhibit 127: Eisai Co. Ltd. - Overview
Exhibit 128: Eisai Co. Ltd. - Business segments
Exhibit 129: Eisai Co. Ltd. - Key offerings
Exhibit 130: Eisai Co. Ltd. - Segment focus
12.8 EpiGentek Group Inc.
Exhibit 131: EpiGentek Group Inc. - Overview
Exhibit 132: EpiGentek Group Inc. - Product / Service
Exhibit 133: EpiGentek Group Inc. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Illumina Inc.
Exhibit 139: Illumina Inc. - Overview
Exhibit 140: Illumina Inc. - Business segments
Exhibit 141: Illumina Inc. - Key news
Exhibit 142: Illumina Inc. - Key offerings
Exhibit 143: Illumina Inc. - Segment focus
12.11 Merck KGaA
Exhibit 144: Merck KGaA - Overview
Exhibit 145: Merck KGaA - Business segments
Exhibit 146: Merck KGaA - Key news
Exhibit 147: Merck KGaA - Key offerings
Exhibit 148: Merck KGaA - Segment focus
12.12 New England Biolabs Inc.
Exhibit 149: New England Biolabs Inc. - Overview
Exhibit 150: New England Biolabs Inc. - Product / Service
Exhibit 151: New England Biolabs Inc. - Key news
Exhibit 152: New England Biolabs Inc. - Key offerings
12.13 Pacific Biosciences of California Inc.
Exhibit 153: Pacific Biosciences of California Inc. - Overview
Exhibit 154: Pacific Biosciences of California Inc. - Product / Service
Exhibit 155: Pacific Biosciences of California Inc. - Key offerings
12.14 PerkinElmer Inc
Exhibit 156: PerkinElmer Inc - Overview
Exhibit 157: PerkinElmer Inc - Business segments
Exhibit 158: PerkinElmer Inc - Key news
Exhibit 159: PerkinElmer Inc - Key offerings
Exhibit 160: PerkinElmer Inc - Segment focus
12.15 QIAGEN NV
Exhibit 161: QIAGEN NV - Overview
Exhibit 162: QIAGEN NV - Product / Service
Exhibit 163: QIAGEN NV - Key news
Exhibit 164: QIAGEN NV - Key offerings
12.16 Thermo Fisher Scientific Inc.
Exhibit 165: Thermo Fisher Scientific Inc. - Overview
Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
Exhibit 167: Thermo Fisher Scientific Inc. - Key news
Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus
12.17 Zymo Research Corp.
Exhibit 170: Zymo Research Corp. - Overview
Exhibit 171: Zymo Research Corp. - Product / Service
Exhibit 172: Zymo Research Corp. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 175: Currency conversion rates for US$
13.4 Research methodology
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources
13.5 List of abbreviations
Exhibit 179: List of abbreviations